Skip to content

Effect and mechanism of hydrogen and oxygen inhalation on postoperative brain edema in patients with brain tumors

Effect and mechanism of hydrogen and oxygen inhalation on postoperative brain edema in patients with brain tumors

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300074362
Enrollment
Unknown
Registered
2023-08-04
Start date
2023-09-01
Completion date
Unknown
Last updated
2023-08-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

encephaledema

Interventions

group A: Oxygen (33.3%)
group B: Oxygen+hydrogen (less than 2 hours)
group C:Oxygen+hydrogen (2 hours - 4 hours)
group D: Oxygen+hydrogen (more than 4 hours)

Sponsors

Sanbo Brain Hospital Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: ? American Association of Anesthesiologists (ASA) grade I or II patients; ? No serious systemic symptoms (such as heart, lung, liver and kidney failure); ? Mini-cog (simple intelligence state assessment form) score 3 points; ? Be able to sign informed consent; ? The anesthesia process is in accordance with the unified anesthesia plan, and the infusion volume is adjusted according to the PPV results, so as to strictly avoid perioperative fluid overload

Exclusion criteria

Exclusion criteria: ? Pregnant and lactating women; ? Mentally or physically disabled patients; ? Have a history of serious heart disease; ? Known intolerance to inhalation therapy; ? It is difficult to attach the electrode because the operation area is too rough, such as after bilateral bone flap removal; ? Other situations that cannot be monitored, such as allergy to electrode patches; ? Malignant encephalocele or other monitoring electrodes will be harmful to the patient's condition; ? Other situations that cannot be monitored

Design outcomes

Primary

MeasureTime frame
Course of cerebral edema;

Secondary

MeasureTime frame
Matrix metalloproteinase (MMPs);Syndecan-1(Syn-1);Heparanase(HS);hyaluronic acid(HA);C-reactive protein(CRP);Interleukin-6(IL-6);Tumor necrosis factor(TNF-a);

Countries

China

Contacts

Public ContactBaoguo Wang

Sanbo Brain Hospital Capital Medical University

ltmzvip@163.com+86 10 6285 6766

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 6, 2026